Current
Neuro-Oncology

Volume 20 Number 1
31 January 2018

Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 1, 31 January

Nikolov V, Stojanovic M, Kostic A, Radisavljevic M, Simonovic N, Jelenkovic B, Berilazic L.
Factors affecting the survival of patients with glioblastoma multiforme.
J BUON. 2018 Jan-Feb;23(1):173-178→. PMID: 29552779→. Observational study. ˍ

Rahman MM, Rahman SM, Ahmed S, Parveen S, Lailatunnessa M.
Gliomatosis Cerebri: A Rare Brain Tumor.
Mymensingh Med J. 2018 Jan;27(1):209-211[No link available]. PMID: 29459616→. Case report˰ ˍ

Johanns TM, Ferguson CJ, Grierson PM, Dahiya S, Ansstas G.
Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF-Mutated High-Grade Glioma.
J Natl Compr Canc Netw. 2018 Jan 1, 2018;16(1):4-10→. doi: 10.6004/jnccn.2017.7032→. PMID: 29295876→. Case report. ˍ

Magge RS.
How Helpful Is Bevacizumab in Recurrent Glioblastoma?
Relias (AHC Media). 2018 Jan 1→. Comment. ˍ
Refers to: Wick W, et al., Lomustine and bevacizumab in progressive glioblastoma. N Engl J Med. 2017 Nov 16, 2017;377(20):1954-1963→. doi: 10.1056/NEJMoa1707358→. PMID: 29141164→. Interventional study. ˍ

Wann A, Tully PA, Barnes EH, Lwin Z, Jeffree R, Drummond KJ, Gan H, Khasraw M.
Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.
J Neurooncol. 2018 Jan 2, 2018;137(2):409-415→. doi: 10.1007/s11060-017-2731-2→. PMID: 29294233→. Observational study. ˍ

Schiff D, Jaeckle KA, Anderson SK, Galanis E, Giannini C, Buckner JC, Stella P, Flynn PJ, Erickson BJ, Schwerkoske JF, Kaluza V, Twohy E, Dancey J, Wright J, Sarkaria JN.
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.
Cancer. 2018 Jan 3, 2018;124(7):1455-1463→. doi: 10.1002/cncr.31219→. PMID: 29313954→. Interventional study. ˍ

Straube C, Scherb H, Gempt J, Kirschke J, Zimmer C, Schmidt-Graf F, Meyer B, Combs SE.
Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
BMC Cancer. 2018 Jan 3, 2018;18(1):15→. doi: 10.1186/s12885-017-3928-7→. PMID: 29298660→. Interventional study Protocol. ˍ

Chin AL, Moding EJ, Donaldson SS, Gibbs IC, Soltys SG, Hiniker SM, Pollom EL.
Survival Impact of Postoperative Radiotherapy Timing in Pediatric and Adolescent Medulloblastoma.
Neuro Oncol. 2018 Jan 4, 2018;20(8):1133-1141→. doi: 10.1093/neuonc/noy001→. PMID: 29309676→. Observational study. ˍ

.

Goldman DA, Hovinga K, Reiner AS, Esquenazi Y, Tabar V, Panageas KS.
The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
J Neurosurg. 2018 Jan 5, 2018;129(5):1231-1239→. doi: 10.3171/2017.6.JNS17393→. PMID: 29303449→. Observational study. ˍ

Prust ML, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, Dietrich J.
Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss.
Neuro Oncol. 2018 Jan 5, 2018;20(2):289-291→. doi: 10.1093/neuonc/nox217→. PMID: 29315410→. Letter to the Editor / Observational study. ˍ

Lee JE, Lim JH, Hong YK, Yang SH.
High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy.
Cancer Res Treat. 2018 Jan 10, 2018;50(4):1331-1342→. doi: 10.4143/crt.2017.466→. PMID: 29334602→. Laboratory investigation. ˍ

Franceschi E, Tosoni A, Minichillo S, Depenni R, Paccapelo A, Bartolini S, Michiara M, Pavesi G, Urbini B, Crisi G, Cavallo MA, Tosatto L, Dazzi C, Biasini C, Pasini G, Balestrini D, Zanelli F, Ramponi V, Fioravanti A, Giombelli E, De Biase D, Baruzzi A, Brandes AA; PERNO Study Group.
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power.
World Neurosurg. 2018 Jan 11, 2018;112:e342-e347→. doi: 10.1016/j.wneu.2018.01.045→. PMID: 29337169→. Observational study. ˍ

.

Jakobsen JN, Urup T, Grunnet K, Toft A, Johansen MD, Poulsen SH, Christensen IJ, Muhic A, Poulsen HS.
Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients.
J Neurooncol. 2018 Jan 12, 2018;137(2):439-446→. doi: 10.1007/s11060-017-2736-x→. PMID: 29330749→. Observational study. ˍ

*

Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn PO.
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
J Neurosurg. 2018 Jan 12, 2018;129(6):1446-1455→. doi: 10.3171/2017.7.JNS17668→. PMID: 29328002→. Laboratory investigation. ˍ

.

Grahnke KA, Heiferman DM, Borys E, Melian E, Barton KP, Lukas RV, Shaikh N, Leonetti JP, Anderson DE.
Delayed leptomeningeal metastasis of an adult anaplastic pilocytic astrocytoma.
Brain Tumor Pathol. 2018 Jan 13, 2018;35(2):123-126→. doi: 10.1007/s10014-017-0306-8→. PMID: 29330645→. Case report. ˍ

Youland RS, Pafundi DH, Brinkmann DH, Lowe VJ, Morris JM, Kemp BJ, Hunt CH, Giannini C, Parney IF, Laack NN.
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
J Neurooncol. 2018 Jan 13, 2018;137(3):583-591→. doi: 10.1007/s11060-018-2750-7→. PMID: 29330751→. Interventional study. ˍ

Im JH, Hong JB, Kim SH, Choi J, Chang JH, Cho J, Suh CO.
Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification.
Sci Rep. 2018 Jan 15, 2018;8(1):777→. doi: 10.1038/s41598-017-19014-1→. PMID: 29335518→. Observational study. ˍ

Graham-Gurysh E, Moore KM, Satterlee AB, Sheets KT, Lin FC, Bachelder EM, Miller CR, Hingtgen SD, Ainslie KM.
Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
Mol Pharm. 2018 Jan 17, 2018;15(3):1309-1318→. doi: 10.1021/acs.molpharmaceut.7b01114→. PMID: 29342360→. Laboratory investigation. ˍ

Atalar B, Ozsahin M, Call J, Napieralska A, Kamer S, Villa S, Erpolat P, Negretti L, Lassen-Ramshad Y, Onal C, Akyurek S, Ugurluer G, Baumert BG, Servagi-Vernat S, Miller RC, Ozyar E, Sio TT.
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Radiother Oncol. 2018 Jan 18. 2018;127(1):96-102→. doi: 10.1016/j.radonc.2017.12.028→. PMID: 29373196→. Observational study. ˍ

Siddiqui J, Krishnan AS.
Butterfly Glioma.
N Engl J Med. 2018 Jan 18, 2018;378(3):281→. doi: 10.1056/NEJMicm1704713→. PMID: 29342386→. Case report. ˍ

Emmanuel C, Lawson T, Lelotte J, Fomekong E, Vaz G, Renard L, Whenham N, Raftopoulos C.
Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
J Neurosurg Sci. 2018 Jan 23, 2019;63(3):251-257→. doi: 10.23736/S0390-5616.18.04180-2→. PMID: 29363298→. Observational study˰ ˍ

Lassaletta A, Strother D, Laperriere N, Hukin J, Vanan MI, Goddard K, Lafay-Cousin L, Johnston DL, Zelcer S, Zapotocky M, Rajagopal R, Ramaswamy V, Hawkins C, Tabori U, Huang A, Bartels U, Bouffet E.
Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.
Pediatr Blood Cancer. 2018 Jan 25, 2018 Jun;65(6):e26988→. doi: 10.1002/pbc.26988→. PMID: 29369515→. Observational study. ˍ

Bronnimann C, Izquierdo C, Cartalat S, Thomas L, Joubert B, Delpech L, Barritault M, Meyronet D, Honnorat J, Ducray F.
Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.
J Neurooncol. 2018 Jan 31, 2018;138(1):141-145→. doi: 10.1007/s11060-018-2780-1→. PMID: 29388033→. Observational study. ˍ

Kunikowska J, Bartosz K, Leszek K.
Glioblastoma multiforme: another potential application for ⁶⁸Ga-PSMA PET/CT as a guide for targeted therapy.
Eur J Nucl Med Mol Imaging. 2018 Jan 31, 2018;45(5):886-887→. doi: 10.1007/s00259-018-3934-2→. PMID: 29387926→. Case report. ˍ

Li HY, Sun CR, He M, Yin LC, Du HG, Zhang JM.
Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
World Neurosurg. 2018 Jan 31, 2018;112:e407-e414→. doi: 10.1016/j.wneu.2018.01.055→. PMID: 29355809→. Observational study. ˍ